CRISPR crew’s lab test spot­lights lead pro­gram in sick­le cell dis­ease, be­ta-tha­lassemia

CRISPR/Cas9 tech is still at a very ear­ly stage of de­vel­op­ment. But one of the top biotechs look­ing to make a break­through in the clin­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.